Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Luke Gaughan

Newcastle AuthorsTitleYearFull text
Professor Rakesh Heer
Dr Luke Gaughan
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients2024
Dr Laura Walker
Dr Ruaridh Duncan
Dr Beth Adamson
Hannah Kendall
Dr Nicholas Brittain
et al.		Defining splicing factor requirements for androgen receptor variant synthesis in advanced prostate cancer2024
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.		ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2024
Dr Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al.		Engineering prostate cancer in vitro: what does it take?2023
Rebecca Harris
Dr Maninder Heer
Dr Mark Levasseur
Dr Tyrell Cartwright
Beth Weston
et al.		Release of Histone H3K4-reading transcription factors from chromosomes in mitosis is independent of adjacent H3 phosphorylation2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.		ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2023
Dr Beth Adamson
Dr Nicholas Brittain
Dr Laura Walker
Ruaridh Duncan
Dr Sara Luzzi
et al.		The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer2023
Dr Luke Gaughan
Dr Ian Logan
Professor Craig Robson
Correction to: Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation (Nucleic Acids Research (2005) 33 (13-26) DOI: 10.1093/nar/gki141)2021
Dr Luke Gaughan
SLFN5 regulates LAT1-Mediated mTOR activation in castration-resistant prostate cancer2021
Dr Luke Gaughan
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer2020
Alex Bainbridge
Dr Scott Walker
Joseph Smith
Yi Min Ng Ng
Huw Thomas
et al.		IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway2020
Dr Anastasia Hepburn
Emma Curry
Dr Mohammad Moad
Laura Wilson
Parmveer Singh
et al.		Propagation of human prostate tissue from induced pluripotent stem cells2020
Evangelia Kounatidou
Dr Sirintra Nakjang
Dr Stuart McCracken
Professor Craig Robson
Dr Dominic Jones
et al.		A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities2019
Evangelia Kounatidou
Dr Luke Gaughan
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer2019
Dr Anastasia Hepburn
Laura Wilson
Evangelia Kounatidou
Amy Barnard
Philip Berry
et al.		Correction: The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene, (2019), 10.1038/s41388-019-0712-y)2019
1234